Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760 This issue

Erratum

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum

Renjie Yang1,2#, Dong Wang2#, Shen Han2#, Yichao Gu2#, Zhi Li2, Lei Deng2, Aihong Yin2, Yun Gao2, Xiangcheng Li2, Yue Yu2✉, Xuehao Wang1,2✉

1. School of Medicine, Southeast University, Nanjing, China.
2. Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province, China.
#These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760. Available from https://www.ijbs.com/v18p4466.htm

File import instruction

Corrected-article in Int J Biol Sci, Volume 18, 43